A comprehensive analysis of glycan expression in 16 organoids derived from 14 pancreatic cancer patients showed that the reactivity of fucose-binding lectins (AAL, AOL) was higher in 13 KRAS mutant organoids compared to 3 wild-type organoids. This evidence concerns the gene KRAS and pancreatic neoplasm.